Suppr超能文献

电子健康记录界面设计对环孢素、他克莫司和地尔硫卓不安全处方的影响:英国国家卫生服务初级保健中的队列研究。

Impact of Electronic Health Record Interface Design on Unsafe Prescribing of Ciclosporin, Tacrolimus, and Diltiazem: Cohort Study in English National Health Service Primary Care.

机构信息

The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.

出版信息

J Med Internet Res. 2020 Oct 16;22(10):e17003. doi: 10.2196/17003.

Abstract

BACKGROUND

In England, national safety guidance recommends that ciclosporin, tacrolimus, and diltiazem are prescribed by brand name due to their narrow therapeutic windows and, in the case of tacrolimus, to reduce the chance of organ transplantation rejection. Various small studies have shown that changes to electronic health record (EHR) system interfaces can affect prescribing choices.

OBJECTIVE

Our objectives were to assess variation by EHR systems in breach of safety guidance around prescribing of ciclosporin, tacrolimus, and diltiazem, and to conduct user-interface research into the causes of such breaches.

METHODS

We carried out a retrospective cohort study using prescribing data in English primary care. Participants were English general practices and their respective EHR systems. The main outcome measures were (1) the variation in ratio of safety breaches to adherent prescribing in all practices and (2) the description of observations of EHR system usage.

RESULTS

A total of 2,575,411 prescriptions were issued in 2018 for ciclosporin, tacrolimus, and diltiazem (over 60 mg); of these, 316,119 prescriptions breached NHS guidance (12.27%). Breaches were most common among users of the EMIS EHR system (breaches in 18.81% of ciclosporin and tacrolimus prescriptions and in 17.99% of diltiazem prescriptions), but breaches were observed in all EHR systems.

CONCLUSIONS

Design choices in EHR systems strongly influence safe prescribing of ciclosporin, tacrolimus, and diltiazem, and breaches are prevalent in general practices in England. We recommend that all EHR vendors review their systems to increase safe prescribing of these medicines in line with national guidance. Almost all clinical practice is now mediated through an EHR system; further quantitative research into the effect of EHR system design on clinical practice is long overdue.

摘要

背景

在英国,国家安全指南建议由于环孢素、他克莫司和地尔硫䓬的治疗窗较窄,且在他克莫司的情况下为降低器官移植排斥的可能性,应按品牌名开具处方。多项小型研究表明,电子健康记录(EHR)系统接口的更改会影响处方选择。

目的

我们的目标是评估 EHR 系统之间在违反环孢素、他克莫司和地尔硫䓬处方安全指南方面的差异,并对口服用药界面研究进行研究,以找出导致这种违规行为的原因。

方法

我们使用英国初级保健中的处方数据开展了一项回顾性队列研究。参与者为英国全科医生及其各自的 EHR 系统。主要结局指标为:(1)所有实践中安全违规与遵医嘱用药的比例差异;(2)对 EHR 系统使用情况的描述。

结果

2018 年共开具了 2575411 份环孢素、他克莫司和地尔硫䓬(超过 60mg)的处方;其中,316119 份处方违反了国民保健制度的指导原则(12.27%)。在使用 EMIS EHR 系统的用户中,违规行为最为常见(环孢素和他克莫司处方中有 18.81%违规,地尔硫䓬处方中有 17.99%违规),但在所有 EHR 系统中均观察到了违规行为。

结论

EHR 系统的设计选择对环孢素、他克莫司和地尔硫䓬的安全处方有很大影响,在英国的全科医生中,违规行为普遍存在。我们建议所有 EHR 供应商审查其系统,以增加这些药物的安全处方,使其符合国家指导原则。几乎所有的临床实践现在都通过 EHR 系统进行;进一步对口服用药界面研究对临床实践的影响进行定量研究已迫在眉睫。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ee3/7600019/1932023b2169/jmir_v22i10e17003_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验